The Centers for Medicare and Medicaid Services (CMS) has released a summary of each HCPCS Level II code application decision. The document is twenty-eight pages long and the link can be found in the Resources section.
There are 23 items included in the Second Quarter 2024 Drug and Biological decisions. Twenty new codes have been established. There is one title revision and two code deletions.
| Title | Decision | HCPCS Code | Description |
| Docivyx | Title Revision | J9172 | Change manufacturer from Ingenus to Avyxa |
| Xenoview™ | Add | A9610 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
| Delete | J9150 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose | |
| Aurlumyn™ | Add | J1749 | Inj, iloprost, 0.1mcg |
| Combogesic ® | Add | J0138 | Inj, acetaminophen 10 mg and ibuprofen 3 mg |
| Paclitaxol Protein Bound Particles | Delete | J9258 | Inj, paclitaxel protein-bound particles (teva) not therapeutically equivalent to J9264, 1 mg. |
| Jubbonti & Wyost | Add | Q5136 | Inj, denosumab-bbdz, biosimilar, 1 mg |
| TYENNE ® | Add | Q5135 | Inj, tocilizumab-aazg, biosimilar, 1 mg |
| TEVIMBRA | Add | Q9329 | Inj, tislelizumab-jsgr, 1 mg |
| KISUNLA™ | Add | J0175 | Inj, donanemab-azbt, 2 mg |
| Baxter’s Vasopressin in Sodium Chloride | Add | J2601 | Inj, vasopressin (baxter), 1 unit |
| Tri-Membrane Wrap | Add | Q4344 | Tri-membrane wrap, per square centimeter |
| Dermacyte® AC Matrix Amniotic Membrane Allograph | Add | Q4343 | Dermatocyte ac matrix amniotic membrane allograph, per square centimeter |
| TheraMend | Add | Q4342 | Theramend, per square centimeter |
| Matrix HD Allograft Dermis | Add | Q4345 | Matrix hd allograft dermis, per square centimeter |
| Artacent C | Add | Q4336 | Artacent c, per square centimeter |
| Artacent Trident | Add | Q4337 | Artacent trident, per square centimeter |
| Artacent Velos | Add | Q4338 | Artacent velos, per square centimeter |
| Artacent VeriClen | Add | Q4339 | Artacent vericlen, per square centimeter |
| AmnioPlast 1 ™ | Add | Q4334 | Amnioplast 1, per square centimeter |
| AmnioPlast 2 ™ | Add | Q4335 | Amnioplast 2, per square centimeter |
| SimpliMax | Add | Q4341 | Simplimax, per square centimeter |
| SimpliGraft | Add | Q4340 | Simpligraft, per square centimeter |
It is recommended to review the application results to determine when the code becomes active or inactive.
There is also an analysis of HCPCS codes for products approved by the Food and Drug Administration (FDA) under the 505(b)(2) NDA and BLA Pathways and Products Not Otherwise Classified. The results are eight new codes, one revision, and four deletions as shown below:
The release of the application decisions means that the chargemaster coordinator must review the chargemaster to see if the changes impact the file.
Each of the added items should be discussed with the pharmacy department or chief medical officer (CMO) to determine if there is a plan to add these drugs and biologicals to the formulary. Pharmaceuticals can be difficult because of the translation that is made from the units described in the code description to the usual dosage amount.
The HCPCS codes are updated on a quarterly basis so this process should occur with each release. It is important to avoid unnecessary claim denials due to inactive codes or missed charges because the new codes are not available for reporting.
Resources:
2024-hcpcs-application-summary-quarter-2-2024-drugs-and-biologicals.pdf (cms.gov)
EDITOR’S NOTE: The author of this article used AI-assisted tools in its composition, but all content, analysis, and conclusions were based on the author’s professional
While the coverage of telehealth is definitely a good thing, it has caused needless confusion. I would like to address a little of that today.
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
